Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • NicoBxl
    not just another member
    • Aug 2010
    • 264

    #1

    IGV reverse strand gff

    Hi,

    I've to load a gff3 file in IGV. For the + strand entry it's ok but for the reverse strand entry, I can't see the exon. Here's an example of my gff file :

    Code:
    seqId	ensembl	mRNA	31592154	31588264	.	-	.	ID=ENSBTAG00000000008|ENSBTAT00000000008_0;Name=ENSBTAG00000000008|ENSBTAT00000000008
    seqId	ensembl	exon	31592154	31592115	.	-	.	ID=ENSBTAG00000000008|ENSBTAT00000000008_0_0;Name=ENSBTAG00000000008|ENSBTAT00000000008_0;Parent=ENSBTAG00000000008|ENSBTAT00000000008_0
    seqId	ensembl	exon	31589404	31588264	.	-	.	ID=ENSBTAG00000000008|ENSBTAT00000000008_0_1;Name=ENSBTAG00000000008|ENSBTAT00000000008_1;Parent=ENSBTAG00000000008|ENSBTAT00000000008_0
    The mRNA are well drawed but the exon aren't there ...

    Is my gff file ok?

    Thanks,

    N.
  • NicoBxl
    not just another member
    • Aug 2010
    • 264

    #2
    RESOLVED

    my gff file wasn't ok

    now it works

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:13 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Working...